Pfizer says study shows vaccinating pregnant women protects newborns from RSV

Indonesia Berita Berita

Pfizer says study shows vaccinating pregnant women protects newborns from RSV
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 ABC7Chicago
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 63%

A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV.

Pfizer announced Tuesday that a large international study found vaccinating moms-to-be was nearly 82% effective at preventing severe cases of RSV in their babies' most vulnerable first 90 days of life. At age 6 months, the vaccine still was proving 69% effective against serious illness - and there were no signs of safety problems in mothers or babies.

None of the findings will help this year when an early RSV surge already is crowding children's hospitals. But they raise the prospect that one or more vaccines might become available before next fall's RSV season. A tragedy in the 1960s set back the whole field. Using the approach that led to the first polio vaccine, scientists made an experimental RSV vaccine by growing the virus in a lab and killing it. But testing in children found not only was the vaccine not protective, youngsters who caught RSV after vaccination fared worse. Two died.

It turns out that the immune system only forms effective RSV-fighting antibodies when it spots what's called the pre-fusion version of that protein, explained structural biologist Jason McLellan of the University of Texas at Austin.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

ABC7Chicago /  🏆 284. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

How To Stay Safe As Flu and RSV Cases Reach Record HighsFlu-related hospitalizations are at a 13-year high for this time of year and RSV cases continue to climb, tripling over the last two months.
Baca lebih lajut »

U.S. Could Quickly Face Tripledemic of RSV, COVID, and FluU.S. Could Quickly Face Tripledemic of RSV, COVID, and FluExperts are warning about a tripledemic of respiratory viruses. Here’s what could be ahead, and how to stay safe.
Baca lebih lajut »

New Hybrid Virus Discovered as Flu And RSV Fuse Into Single PathogenNew Hybrid Virus Discovered as Flu And RSV Fuse Into Single PathogenResearchers have witnessed two viruses – influenza A and respiratory syncytial virus – fuse together to form a single, hybrid virus.
Baca lebih lajut »

Strong RSV vaccine data lifts hopes after years of futilityStrong RSV vaccine data lifts hopes after years of futilityA new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV. rsv vaccine health kprc2 click2houston
Baca lebih lajut »

Strong RSV vaccine data lifts hopes after years of futilityStrong RSV vaccine data lifts hopes after years of futilityEfforts to create a vaccine have failed for decades but some recent promising studies are raising hopes that one might finally be getting close.
Baca lebih lajut »

Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data showsPfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data showsPfizer said it will submit an application to the Food and Drug Administration for the RSV vaccine's approval by the end of 2022.
Baca lebih lajut »



Render Time: 2025-03-07 03:08:10